NYSE:EHC
Encompass Health Corp
A premier US-based healthcare services leader specializing in pain management, spine surgery, and rehabilitation with consistent revenue and earnings expansion.
Key Metrics
Investment Thesis
Bull Case
The consistent double-digit revenue and earnings growth demonstrates strong secular tailwinds in the elective surgery and rehabilitation markets. High operating margins generated by a large-scale, standardized business model provide resilience against inflationary pressures. The company's strategic focus on value-based care contracts offers visibility into future cash flows while diversifying revenue away from traditional fee-for-service volatility.
Bear Case
The substantial net change in cash of -$20.2M and heavy investing cash outflows indicate aggressive M&A activity that could dilute returns if integration fails. High goodwill on the balance sheet of $1.32B creates potential impairment risks should patient volumes decline or regulatory headwinds emerge. Valuation multiples may be compressed if the broader healthcare sector faces a downturn in elective procedure demand.
About Encompass Health Corp
Encompass Health Corp is a leading healthcare services provider operating across the United States with a focus on pain management, spine surgery, and rehabilitation. The company serves a diverse patient base through its extensive network of ambulatory surgical centers, hospital-based clinics, and outpatient therapy facilities. Revenue growth driven by expanding service lines and strategic acquisitions positions the firm as a key player in the value-based care landscape.
Analysis
Management Discussion
Financial performance has strengthened significantly, with revenue climbing from $4.35B in 2022 to $5.94B in 2025, reflecting successful organic growth and acquisitions. Net income followed a parallel upward trajectory, increasing from $365.9M to $759.1M over the same period, driven by expanding patient volumes and operational leverage. Cash flow from operations remains robust at $1.17B, though significant cash outflows for investing activities suggest continued capital deployment for growth initiatives.
Industry Overview
The US healthcare services industry is shifting towards value-based care models that reward quality outcomes and cost efficiency, benefiting providers with specialized capabilities like Encompass Health's spine and pain management. Aging demographics and technological advancements in minimally invasive surgery are driving sustained demand for elective procedures. Consolidation trends favor large, vertically integrated operators capable of negotiating better payer contracts and managing complex regulatory environments.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $4.35B | $4.80B | $5.37B | $5.94B |
| Cost of Revenue | $0 | $0 | $0 | $0 |
| Gross Profit | $4.35B | $4.80B | $5.37B | $5.94B |
| Operating Expenses | $3.81B | $4.19B | $4.62B | $4.98B |
| Operating Income | $539.5M | $607.2M | $749.6M | $953.0M |
| G&A | $154.3M | $201.7M | $209.2M | $236.2M |
| Stock-Based Comp | $29.2M | $50.6M | $48.3M | $56.5M |
| D&A | $243.6M | $273.9M | $299.6M | $327.9M |
| Depreciation | $187.3M | $215.7M | $245.1M | $273.9M |
| Amortization | $28.8M | $32.5M | $28.8M | $28.3M |
| Other OpEx | $3.65B | $3.99B | $4.41B | $4.75B |
| Non-Operating Income | $-88.7M | $0 | $0 | $0 |
| Interest Expense | $175.7M | $143.5M | — | — |
| Pre-Tax Income | $450.8M | $607.2M | $749.6M | $953.0M |
| Income Tax | $100.1M | $132.2M | $150.2M | $192.9M |
| Continuing Ops | $350.7M | $475.0M | $599.4M | $760.1M |
| Discontinued Ops | $15.2M | $-12.0M | $-2.8M | $-1.0M |
| Net Income | $365.9M | $463.0M | $596.6M | $759.1M |
| Minority Interest | $94.9M | $111.0M | $140.9M | $192.9M |
| Net to Common | $271.0M | $352.0M | $455.7M | $566.2M |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Current Assets | $717.2M | $841.8M | $886.9M | $905.9M |
| Cash & Equivalents | $21.8M | $69.1M | $85.4M | $72.2M |
| Accounts Receivable | $524.8M | $599.8M | $593.0M | $613.4M |
| Prepaid Expenses | $127.0M | — | — | — |
| Other Current Assets | $43.6M | $172.9M | $208.5M | $220.3M |
| Long-Term Assets | $4.92B | $5.26B | $5.65B | $6.18B |
| Intangibles | $282.3M | $278.2M | $297.8M | $308.3M |
| Goodwill | $1.26B | $1.28B | $1.28B | $1.32B |
| Operating Leases | $212.5M | $208.5M | $203.7M | $212.6M |
| Other LT Assets | $3.16B | $3.49B | $3.86B | $4.35B |
| Total Assets | $5.64B | $6.10B | $6.53B | $7.09B |
| Current Liabilities | $575.9M | $656.4M | $841.0M | $836.4M |
| Accounts Payable | $132.9M | $170.0M | $171.0M | $178.2M |
| Current Leases | $25.6M | $24.1M | $26.3M | $26.5M |
| Other Current Liab | $417.4M | $462.3M | $643.7M | $576.9M |
| Long-Term Liabilities | $3.20B | $3.15B | $2.84B | $2.98B |
| LT Operating Leases | $199.7M | $196.1M | $189.7M | $196.6M |
| Other LT Liab | $3.00B | $2.95B | $2.65B | $2.78B |
| Total Liabilities | $3.77B | $3.81B | $3.69B | $3.81B |
| Shareholders' Equity | $1.86B | $2.30B | $2.85B | $3.28B |
| Paid-In Capital | $1.73B | $1.79B | $1.85B | $1.87B |
| Retained Earnings | $115.7M | $406.5M | $796.7M | $1.29B |
| AOCI | — | — | — | $500.0K |
| Total L&E | $5.64B | $6.10B | $6.53B | $7.09B |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net Income (CFO) | $365.9M | $463.0M | $596.6M | $759.1M |
| Non-Cash Adjustments | $352.5M | $288.9M | $272.6M | $318.0M |
| Working Capital Changes | $-12.6M | $82.9M | $130.5M | $97.1M |
| Cash from Operations | $705.8M | $834.8M | $999.7M | $1.17B |
| Capital Expenditures | $564.8M | — | — | — |
| Cash from Investing | $-627.0M | $-602.8M | $-653.3M | $-764.6M |
| Share Buybacks | $0 | — | $31.1M | $158.0M |
| Dividends Paid | $99.0M | $60.4M | $62.8M | $71.1M |
| Cash from Financing | $-145.7M | $-197.2M | $-330.6M | $-431.2M |
| FX Effect | $0 | $16.0M | $3.1M | $1.4M |
| Net Change in Cash | $-66.9M | $50.8M | $18.9M | $-20.2M |
| Beginning Cash | $120.3M | $53.4M | $104.2M | $123.1M |
| Ending Cash | $53.4M | $104.2M | $123.1M | $102.9M |
Frequently Asked Questions
How does Encompass Health Corp make money?
The company generates revenue primarily through its Pain Management Centers offering non-surgical and surgical interventions for chronic pain, Spine Surgery centers providing minimally invasive procedures for spinal conditions, and Rehabilitation Services delivering physical therapy and post-operative care. Additional streams include Orthopedic Surgery and specialized clinics such as Neurosurgery, Cardiac Care, and Weight Loss programs that cater to growing demand for elective procedures.
What are the main risks for EHC?
Regulatory changes in healthcare reimbursement models could impact margins for elective procedures like spine surgery and pain management. Intense competition from hospital systems and standalone ambulatory surgery centers may pressure pricing or lead to market consolidation. Rising medical malpractice insurance costs and potential litigation related to surgical outcomes pose financial uncertainties. Dependence on physician recruitment and retention in a tight labor market could disrupt operational capacity at key sites.
What is EHC's competitive advantage?
Encompass Health possesses a significant market share in the outpatient spine surgery sector, allowing for high volume operational efficiencies and strong pricing power. The company's integrated care model combining surgery, pain management, and rehabilitation creates a closed-loop patient journey that improves outcomes and reduces readmission rates. A robust proprietary technology platform enables seamless scheduling, billing, and data analytics across its thousands of locations nationwide.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.